351 related articles for article (PubMed ID: 26556710)
1. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
Sun XG; Lin XC; Diao JX; Yu ZL; Li K
Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
[TBL] [Abstract][Full Text] [Related]
2. Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma.
Wu X; Peng M; Huang B; Zhang H; Wang H; Huang B; Xue Z; Zhang L; Da Y; Yang D; Yao Z; Zhang R
Cancer Lett; 2013 Oct; 340(1):124-33. PubMed ID: 23920127
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell defects in the colorectal cancer.
Legitimo A; Consolini R; Failli A; Orsini G; Spisni R
Hum Vaccin Immunother; 2014; 10(11):3224-35. PubMed ID: 25483675
[TBL] [Abstract][Full Text] [Related]
5. Novel avenues in immunotherapies for colorectal cancer.
Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
[TBL] [Abstract][Full Text] [Related]
6. Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?
Cui G; Shi Y; Cui J; Tang F; Florholmen J
Scand J Gastroenterol; 2012 Apr; 47(4):367-77. PubMed ID: 22229663
[TBL] [Abstract][Full Text] [Related]
7. Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update.
Shi Y; Li Z; Zheng W; Liu X; Sun C; Laugsand JB; Liu Z; Cui G
Immunobiology; 2015 Oct; 220(10):1186-96. PubMed ID: 26153874
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression.
Zhong X; Chen B; Yang Z
Cell Physiol Biochem; 2018; 45(1):356-365. PubMed ID: 29402795
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
10. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
Fantini MC; Favale A; Onali S; Facciotti F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression associated with chronic inflammation in the tumor microenvironment.
Wang D; DuBois RN
Carcinogenesis; 2015 Oct; 36(10):1085-93. PubMed ID: 26354776
[TBL] [Abstract][Full Text] [Related]
13. Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes.
Kanterman J; Sade-Feldman M; Biton M; Ish-Shalom E; Lasry A; Goldshtein A; Hubert A; Baniyash M
Cancer Res; 2014 Nov; 74(21):6022-35. PubMed ID: 25209187
[TBL] [Abstract][Full Text] [Related]
14. Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive Microenvironment.
Guo Q; Li J; Lin H
Biomed Res Int; 2015; 2015():261620. PubMed ID: 26161392
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
16. Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer.
Xiong Y; Wang Y; Tiruthani K
Nanomedicine; 2019 Oct; 21():102034. PubMed ID: 31207314
[TBL] [Abstract][Full Text] [Related]
17. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor cells and tumor microenvironment on NK-cell function.
Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
[TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
20. T cell subsets and colorectal cancer: discerning the good from the bad.
Scurr M; Gallimore A; Godkin A
Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
